ReviewWorld journal of surgical oncology2025
Advances in the use of exosomes for the diagnosis and treatment of ovarian cancer.
Review in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian cancer (OC) is the most lethal gynecologic malignancy, with insidious early symptoms and a lack of effective screening often leading to late-stage diagnosis and poor prognosis. Exosomes, extracellular vesicles carrying diverse bioactive molecules, play key roles in OC pathogenesis and progression. This review systematically outlines recent advances in exosome research, highlighting their dual potential as liquid biopsy biomarkers for early diagnosis and prognosis, and as natural drug delivery systems for targeted therapy. We also critically analyze the major challenges in clinical translation. Despite existing hurdles, exosome-based strategies hold significant promise for advancing precision medicine in OC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.